SCHEMBL3946288

SCHEMBL3946288

CCCCSc1nccc(OS(=O)(=O)C(F)(F)F)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ADORA3 P0DMS8 1/20 0.35
HASPIN Q8TF76 3/20 0.34
GPR84 Q9NQS5 1/20 0.33
PDE4A P27815 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33
MAPT P10636 2/20 0.33
ALOX15 P16050 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
DRD2 P14416 2/20 0.32
DRD3 P35462 2/20 0.32
DRD1 P21728 1/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3950317 0.79 P2RY12 (0.49) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL23714717 0.71 PDE4A (0.35) PDE4APDE4CPDE4DDRD2DRD3
SCHEMBL22124736 0.70 PDE4A (0.40) PDE4APDE4CPDE4D
SCHEMBL2462671 0.70 LNPEP (0.41) SMN1; SMN2PPARGLMNAHTT
SCHEMBL227790 0.69 KCNH2 (0.45) PDE4APDE4CPDE4DDRD2DRD3
SCHEMBL3809031 0.68 HASPIN (0.42) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL15237684 0.67 MCHR1 (0.55) PDE4APDE4CPDE4DDRD2DRD3
SCHEMBL5958929 0.67 CA1 (0.42) PPARG
SCHEMBL16922264 0.66 PDE4A (0.47) PDE4APDE4CPDE4D
SCHEMBL6293194 0.66 L3MBTL1 (0.33) RAB9APDE4APDE4CPDE4DPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009022185-A2 6, 6-FUSED HETEROCYCLES, THEIR PHARMACEUTICAL COMPOSITIONS AND METHOS OF USE ASTRAZENECA AB (SE) 2009-02-19 WO disclosed